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The future of medicine is increasingly in the hands of those
who are effective users of clinical data. To date, this activity has
been dominated by organizations with the resources and
infrastructure to collect and analyze data—typically, payers,
large managed care organizations and the government. The
American College of Cardiology (ACC) and a handful of
medical professional associations are unique in that their
leadership was quick to recognize how important outcomes
data sets would be in ensuring quality patient care and in
establishing a place for clinicians in setting the agenda for
health care.
The ACC has had a clinical database for 5 years. The
process of developing a national database is not a simple one,
and there have been few precedents. It is the purpose of this
report to present the progress to date in the creation of the
ACC National Cardiovascular Data Registry (ACC-NCDR)
and the plan for future developments. Reader comments are
welcome and should be addressed to William S. Weintraub,
MD, FACC, the Chair of the ACC Database Committee.
Purpose of the Registry
Before even starting to describe the registry design, it is
most important to articulate what the registry should accom-
plish. There are several possibilities. The registry could be used
as a national guide for facilities management. By facilities
management, we mean writing catheterization reports, manag-
ing inventory and other tasks. The registry could be used as a
national standard for evaluating the efficacy of new forms of
therapy. It could be used as a basis for a cooperative effort at
performing clinical trials or for evaluating medical care deliv-
ery (i.e., efficacy vs. effectiveness). It is the latter purpose,
effectiveness, that has driven the evolution of the ACC-NCDR.
As a national repository of data for the evaluation of
cardiovascular health care delivery, the College is in a unique
position to address issues that relate to the processes and
outcomes of quality cardiovascular care. The size and scope of
the ACC-NCDR, although fundamental to the value of this
effort, will necessitate relatively slow movement into new areas
and with somewhat less efficiency than other data collection
efforts that are smaller in scope. Furthermore, although ideally
suited for supporting the continuous quality improvement
activities of its participants, the ACC-NCDR will never sup-
plant clinical trials in addressing the efficacy of new treatments.
By virtue of the special relationship and responsibility of
physicians as providers of patient care, the ACC is positioned
to serve as an impartial arbiter of the quality of care. Most
clinicians are only vaguely aware that insurance companies
(Medical Information Bureau), large provider systems (Kaiser
Permanente, Veterans Hospitals), Medicare (MEDPARS)
and large health maintenance organization (HMO) providers
are collecting patient or provider-identified clinical data. These
efforts do not provide relevant clinical information to providers
or patients at the point of care, where they might facilitate
medical decisions. Clinicians and patients do not determine
their structure and operation. The accuracy and analyses of
their data cannot be verified. The availability of the data to
“outside” purchasers and the confidentiality and security of the
data are not known or controlled by clinicians or patients. The
ACC is assuming a leadership role in the design and promul-
gation of its own high quality database that is both guided by
physicians and grounded in sound scientific principles.
Registries should have several essential characteristics that
include open access to participation, uniform definitions and
data reporting standards, audited data, dispassionate scientific
analysis and availability of specific data and comparative
analyses to participating clinicians and their patients at the
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point of care. Today, no existing clinical registry fully meets all
of these goals. However, the closest approximations to this
paradigm are the data collection efforts being organized by
professional medical societies. The ophthalmology, orthope-
dics and medical and surgical cardiovascular societies are now
devoting considerable resources to developing high quality
multicenter clinical data repositories.
The Database Committee has been most interested in
establishing a high quality multicenter clinical data registry
that will permit the broadest assessment of cardiovascular
health care delivery and effectiveness of treatment across the
United States. It has been the policy of the ACC Database
Committee to avoid involvement in facilities management, as
this was felt to be best left to local operations and to software
vendors. Thus, the ACC-NCDR has a well defined niche in the
assessment of health care delivery. In addition, the ACC
Database Committee has responsibilities in education con-
cerning data collection and interpretation as well as in setting
standards of what data are of greatest interest and how the
data may be defined.
Historical Development of the ACC-NCDR
Development of what has become the ACC-NCDR was
initiated in 1987 under the auspices of the ACC Computer
Applications Committee (CAC) and the stewardship of Su-
zanne B. Knoebel, MD, FACC. Dr. Knoebel was visionary in
recognizing the growing importance of outcomes research to
furthering the provision of quality cardiovascular care. As
originally envisioned, the purpose of the ACC clinical database
effort was to demonstrate the effectiveness of specific cardio-
vascular procedures and practices in terms of risk-adjusted
patient outcomes. This purpose was operationalized in a
research perspective characterized by a comprehensive and
powerful data set that could potentially resolve numerous
questions pertinent to targeted procedures.
In September of 1988, a subcommittee of the CAC was
formed under Dr. Knoebel’s leadership to further develop a
clinical angioplasty database. The scope of the subcommittee’s
activities was sufficiently large and complex to warrant the
formation of a separate Database Committee in October of
1989. One of the first products of this new committee was a
marketing study for the new angioplasty database. Database
customers were expected to be institutional participants—
typically, cardiac catheterization laboratories and their associ-
ated facilities. The recommendations of this study were ap-
proved by the ACC Executive Committee, and permission was
given to proceed with the full-scale development of the An-
gioplasty Database in July of 1990. The Database Committee
formed additional subcommittees to develop databases perti-
nent to cardiac catheterization, implantable cardioverter-
defibrillators (ICDs) and radiofrequency (RF) ablation.
It was recognized that ACC would have to seek a contractor
that could provide critical database software development
services. A contract was eventually signed with Summit Med-
ical Systems, Inc., of Minneapolis, to develop and market
database software in February 1991. The first programs for
coronary angioplasty, atherectomy and laser data collection
and for cardiac catheterization data collection were released in
October 1991. The ICD and RF ablation databases were
released in May 1992.
An initial data “harvest” of data from catheterization
laboratories and interventional centers conducted by Summit
in early 1993 suggested that there were problems associated
with data completion. To address this problem, the committee
began an initiative to shorten the elements required for the
coronary angioplasty, atherectomy and laser data collection
effort. A new, shortened data collection form for this database
was approved by the committee in November 1994. However,
there remained multiple problems. The initial forms included
data for both outcomes research and facilities management.
This approach necessarily resulted in an inflexible design that
incorporated many data elements that were of limited value in
assessing clinical effectiveness. In addition, the database did
not include patient identifiers. This created a difficult problem
in assessing angioplasty because patients often have multiple
procedures. Furthermore, given that the primary thrust of the
ACC-NCDR is to support the provision of high quality patient
care, it becomes critical to identify patients so that their
outcomes may be tracked across settings and over time.
Therefore, the Database Committee undertook two parallel
processes to change the orientation of the ACC-NCDR from a
procedure to a patient orientation and from focusing on data
collection forms to the development of a core data set that
would be collected by all participating institutions. This change
in orientation resulted in a restructuring, combining several
distinct databases into one registry, the ACC-NCDR. The
change to patient orientation also creates the need for patient
identifiers, which in turn results in additional requirements for
confidentiality and security.
The relationship of only one company to the ACC-NCDR,
no matter how responsible or capable, restricts participation.
To enhance the institutional coverage of the ACC-NCDR, the
Board of Trustees of the College approved promulgation of
standards by which multiple companies or local institutions
may develop software that will be certified and allow partici-
pation in the ACC-NCDR. These standards plus the core data
elements, associated definitions and coding specifications are
the foundation for all current and future participation.
Core Data Elements
The core data elements have been developed over a period
of 2 years. This list, with associated definitions and coding
specifications, reflects the combined efforts of many leading
cardiovascular epidemiologists, health services researchers,
interventional cardiologists and biostatisticians. The data will
be patient oriented, with the Social Security Number (Social
Insurance Number in Canada) as the primary key identifier.
The core data elements (see Appendix) cover patient demo-
graphics, hospital admission, the procedure (cardiac catheter-
ization or coronary intervention) and discharge. Coronary
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intervention data may be further subdivided by lesion level
details. The elements were selected to permit a broad assess-
ment of intervention in the coronary arteries while not creating
an overwhelming task in data collection. Besides the core
elements there are extended elements. The purpose of the
extended elements is to permit a more detailed assessment.
For instance, the extended elements augment the core ele-
ments with information on discharge medications. Participants
will be asked to collect and submit the core elements. In contrast,
collection of the extended elements will be voluntary. The collec-
tion of the core elements and extended elements is expected to be
with minimal missing data and will be subject to audit.
As noted above, the selection of core elements carried with
it several other tasks. The accompanying data element definitions
reflect a consensus process that included prior efforts by the
Society of Thoracic Surgeons, the New York State Database,
Emory University, Duke University and the University Hospital
Consortium, to name a few. Further, modification of these
definitions may become necessary as the ACC and its Database
Committee work with other organizations on data standards.
Coding specifications were also developed to address both
coding formats and standard edit checks to be incorporated in
the data collection process. Copies of the definitions and
coding specifications may be obtained from Heart House.
Registry Confidentiality and Security
Constraining and controlling the flow of data to protect
confidentiality is essential to the operation of a successful
registry. Despite the tremendous potential benefits, clinical
registries such as the ACC-NCDR face serious barriers to
general participation, partly due to concerns regarding data
confidentiality and security. While these concerns may be an
outgrowth of our Hippocratic tradition, care must be taken to
differentiate professional from commercial data accumulation.
These concerns are not unique and also affect clinical data that
are actively being aggregated into commercial databases. Pa-
tient identifiers are essential to all registries to adequately
address patient outcomes, which require the ability to track
patients across institutions and over time.
Confidentiality refers to the Hippocratic principle noted
above, which requires physicians to protect the privacy of
others. The ACC-NCDR has developed general policies re-
garding confidentiality based on these principles that are
enunciated in forthcoming Participation Guidelines. Informa-
tion that is linked with a particular patient, operator or
institution will be treated as confidential and analyzed and
reported confidentially to participants for use in their own
quality assurance programs. The ACC-NCDR policies empha-
size the participants’ use of the ACC-NCDR reports as tools
for physicians’ continuous quality assurance programs and for
direct physician to physician feedback regarding their practice
patterns, practice outcomes and practice management.
There are five main steps associated with the secure treat-
ment of reported data: 1) An ACC participant agreement shall
be implemented for each participant. 2) All information shall
be sent directly to the ACC Data Analysis Center at Heart
House using specified data elements, data definitions, data
format and encryption protocols. 3) Identifiers will be retained
in separate files that will be linked via an undecipherable key to
the actual patient data records. The identifier files will be kept
off-line in secure storage and used only for file updates and
linkages. They will be scrubbed from the system after each use.
4) Physical and electronic access to data internally at Heart
House will be monitored and granted for specific purposes,
such as data cleaning, feedback to participants and to discuss
specific data analyses. Unauthorized or inappropriate access to
data will carry specific sanctions that include dismissal and
possible legal action where warranted. 5) Data reports will be
routinely monitored to ensure that individual institutions,
providers and patients are unidentifiable directly or indirectly.
Confidential reports will not be released without a formal
sign-off procedure with the receiving institution to ensure that
only appropriately authorized personnel receive the reports.
Most important, since confidentiality is an evolving issue
among professionals, many ACC participants may be aware of
these policies and will be able to suggest amendments directly
to the Database Committee.
Security refers to the specific procedures implemented by
the ACC Database Committee and staff to maintain the
confidentiality policy. The procedures specify the method of
coding data and the transmission methods. They describe in
detail the methods by which physical access and electronic
access to the data are limited. They name individuals autho-
rized to access specific classes of data. They specify the
purposes of data access by these individuals and the methods
by which they communicate data to others. Reviews and
revision of the ACC-NCDR Security program have been
delegated to the Database Committee’s Subcommittee on
Participant Relations and Publications in order to respond to
participants’ concerns.
Standards
Although a national registry must use standard definitions
for terms, there is at present no path in clinical medicine to
establish standard definitions. There has been an effort to
establish a standard for correlates of coronary surgical mortal-
ity, but this has yet to be widely adopted. In June 1996, the
Database Committee, with the support of several industry
partners, sponsored a conference that considered standards for
coronary surgery and angioplasty correlates of mortality and
their definitions. Other areas considered were 1) components
of a standard data element; 2) the process for establishing
standards; and 3) the potential for the establishment of a
permanent standards organization. The components of a stan-
dard for an element include its name, definition, coding
specifications, data type, acceptable range where appropriate
and cross-links to other definitions. The explicit process for
establishing a standard is not well established in clinical
medicine. There are organizations, such as the American
Medical Association, the World Health Organization, the
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National Library of Medicine and the National Institute of
Standards and Technology, which have addressed a standard
medical lexicon. While commendable, these efforts have not
approached a level sufficient to fully characterize the processes
and outcomes of cardiovascular care. The standards process
must include a path that not only allows wide input but also
consensus building and certification of a standard and its
publication. A standards organization, once functioning,
should be able to help solve each of these problems. A
successful standards organization must also be able to gain
wide credibility and include input from multiple sources.
Participant Guidelines
Each institution will receive a detailed guideline for partic-
ipation in the ACC-NCDR. The guide is intended to address a
number of key topics relevant to participation. These include
1) the organization and operations of the ACC Cardiovascular
Data Center (the body within ACC charged with data man-
agement, analysis and reporting; 2) a description of the
products and services that will be offered to participants; 3)
specifications of the qualifying terms for participation; 4) a
discussion of the ACC policies and procedures pertinent to
data confidentiality and the accessing of data maintained in
ACC’s registry; and 5) identification of points of contact for
further information.
In addition, a number of detailed technical appendices will
be included that provide a draft participation agreement, fee
schedule, list of certified software vendors, list of core data
elements and definitions, data edit and record completion
specifications, data transmission specifications, data audit pro-
cedures and the text of the ACC Cardiovascular Data Center
Confidentiality Policy.
It is the intention of the ACC Cardiovascular Data Center
to collect data for the registry on a quarterly basis, subject the
data to automated edits and consistency checks and have each
institution rectify any errors or inconsistencies. The data will
be stored in a relational database. Technical support will be
available during regular business hours, and annual training
sessions on data collection and element definitions will be
offered. TheACCwill provide National Summary and Institution-
Specific Reports to each contributing participant that uses certi-
fied software, that adheres to ACC standard definitions and data
quality specifications and that assigns a designated database
manager to work with the ACC to ensure data integrity.
Data Audit
Data reported from multiple sources will always be suspect
in the absence of auditing. To establish auditing, two problems
must be overcome: 1) expense, and 2) participant resistance.
The expense can be justified if it is minimized and if the
auditing enhances the credibility, and consequently, the value
of the data. Participant resistance is based on the desire to
minimize the intrusiveness of outsiders but can also be over-
come if there is a sense that auditing is worthwhile. It is
unlikely that the data will gain much acceptance in the absence
of auditing. For instance, if an ACC Chapter wants to report to
a state government that patients have a mortality rate that is
consistent with published statistics, the state government may
well reject the data in the absence of an audit. It is also the
position of the Database Committee that risk adjustment in
the absence of an audit is not legitimate. Thus, a participant
that is compared with other institutions that were not audited
may feel that they were compared with institutions whose data
could not be trusted. Therefore, regular auditing becomes an
indispensable part of the process. Since it is not necessary, and
probably not feasible, to audit 100% of all collected data, a
sampling strategy is planned. Further, current plans call for
fairly extensive auditing of the process of data collection that
will include testing and certification of individuals directly
responsible for this activity.
Participant and Chapter Relations
The ACC-NCDR serves its participants and the members
of the College. This represents a wide audience that subsumes
clinicians, hospital administrators, nurses and technicians. The
ACC Database Committee, supported by Heart House staff,
face a challenge in meeting the diverse needs of these disparate
groups. The Database Committee, through the Subcommittee
on Participant Relations and Publications, is working to ensure
prompt two-way communication and to refine reporting appro-
priate to the needs of our constituencies. It is anticipated that
ACC’s state Chapters will be a major focal point for recruit-
ment into the registry, given that most major clinical data
collection initiatives have, to date, been state driven. The com-
mittee has established a liaison with the ACCBoard of Governors
to support state-based activities. A representative of the Board of
Governors will sit on the Database Committee, and a member
will also serve on the Subcommittee on Participant Relations and
Publications. It is anticipated that grouped reporting for all
participants in a state will be available to ACC state Chapters.
Vendor and Government Relations
It is in the interests of the College and participants in the
registry to maintain the best possible relations with software
vendors. As noted above, it was an express ruling of the Board
of Trustees that the registry be open to participation by users
of database software from multiple companies. It is the
position of the Database Committee that all software compa-
nies will be treated equally, provided that they incorporate into
their software a set of core elements, extended elements,
definitions and coding specifications that will be identified by
the ACC Database Committee. The ACC will certify software
vendors as meeting these specified standards. Participants
(individual physician groups, clinics or institutions) will be able
to choose the software most suitable to their own needs.
Separate participant agreements will be signed between the
ACC and the vendor and the participant that outline the
appropriate responsibilities of each party.
462 WEINTRAUB ET AL. JACC Vol. 29, No. 2
ACC NATIONAL DATABASE February 1997:459–65
Several states, led by New York, have undertaken the
development of clinical databases. The ACC Database Com-
mittee believes that the registry can fulfill state reporting needs
regarding cardiovascular care and plans to work through its state
Chapters to establish formal reporting mechanisms. This will
probably be less expensive than each state undertaking the
process separately and will provide uniform standards and adher-
ence to agreed upon definitions. The ACC-NCDR will, in the
near future, be able to make statements as to the quality of the
data by virtue of its either passing or not passing audits. Our
conversations with participants suggest that they favor data being
submitted directly to the registry rather than to the state govern-
ment. With the participant’s approval, ACC would fulfill their
state reporting requirements. State governments may also find the
process easier to implement by having a trusted and impartial
organization involved in assessing the data. It is likely that the
precise arrangements for data transfer and reporting will vary
from state to state, and the Database Committee will depend on
the involvement of the ACC state Chapters and the Board of
Governors in their negotiation and establishment.
National and Local Reporting
The ACC prepares annual national summary reports based
on analyses of the latest data up to a specified cutoff date.
Initial results are usually presented at the ACC Annual Scientific
Session. Because the most recent data submission was still
procedure based, results for the 1996 report focused on summary
data of 137,598 cardiac catheterizations and 124,736 coronary
interventions. Copies of the 1996 National Summary Report can
be obtained by contacting the ACC Cardiovascular Data Center
at Heart House.
Once the ACC-NCDR is converted from a procedural to an
episode-of-care orientation, national summary reports will be
issued to all participants. These reports will include data on
patient characteristics, characteristics of the care provided,
length of stay and complication rates. Mortality and risk factor
reports will be generated as well. Due to the longitudinal
nature of the data, and because strict auditing criteria must be
satisfied, the ACC plans to track repeat procedure status and
build risk-adjusted patient outcome models.
All participants will also be provided with periodic
institution-specific comparative reports. These will include
tabulations on 1) data completeness; 2) volume and resource
utilization; 3) procedure complications and mortality compar-
isons; and 4) risk-adjusted patient outcome parameters for
each site. The ACC will also provide an annual written
evaluation of participating site data collection efforts. This will
include problem areas as well as tips on improving data
gathering and decreasing missing values rates.
Links to Other Registries and
Clinical Databases
Close cooperation with sister associations, including the
Society for Cardiac Angiography and Interventions and the
Society of Thoracic Surgeons, is expected to further develop
over time. Further, the use of the Social Security Number as
the primary key will permit links to other databases, including
the National Death Index and the Health Care Financing
Administration (HCFA) databases. Linking to the National
Death Index would allow follow-up of all patients in the
registry, at least for the end point of death. Linking to the
HCFA database would allow the ACC to examine the rela-
tionship of clinical variables to the cost of care. HCFA
databases include hospital admission claims from the con-
densed hospital bill called the UB92 for most Medicare
recipients. Similar Medicare data for professional billing can
be obtained from the database containing the Current Proce-
dural Technology (CPT) codes as collected on the HCFA 1500
form. Participants may be uncomfortable with the prospect of
the ACC and HCFA sharing data. However, the economic
data obtained through this linkage should considerably en-
hance the usefulness of the registry, and every effort will be
taken to preserve the confidentiality of any linked data.
Furthermore, the availability of appropriately audited and
detailed clinical information will have a salutary effect on the
quality of HCFA’s claims analyses—which should represent a
major benefit to participants.
Education
Medical education is frequently deficient in providing the
skills needed to collect and effectively use clinical data. The
ACC Database Committee has a responsibility to the partici-
pants to offer education concerning which data to collect, how
to collect the data, how to organize staff to do so, how to select
software, how to transmit data to the ACC and how to
interpret data. A multitiered educational initiative is being
planned for the collectors and users of clinical data that covers
classroom/lecture formats and self-learning strategies. In addi-
tion, the ACC plans to certify training programs offered by
software vendors and others to participants on the appropriate
submission and use of ACC-NCDR data.
Education will also be a focus of reports and publications
that have been or are being developed by the ACC Database
Committee. These publications, some of which were referenced
above, include a regular participant newsletter, Data Basis. The
ACC’s home page on the World Wide Web will become an
important mechanism for both information dissemination and for
receiving feedback from our various constituencies.
Additional Areas of Practice
The ACC-NCDR is currently focused on cardiac catheter-
ization and intervention in the coronary arteries. The Database
Committee will gradually move into new areas as the current
efforts continue to mature. Data standardization initiatives,
most recently with the Society of Thoracic Surgeons, represent
an exciting way for engaging other cardiovascular subspecial-
ties in the formation of data sets and may ultimately lead to a
combined database. However, cardiology is not limited to
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revascularization. Preliminary efforts are underway by the
committee to establish an electrophysiology database in con-
cert with the North American Society of Pacing and Electro-
physiology (NASPE). Other areas of interest include echocar-
diography, nuclear cardiology, heart failure, acute myocardial
infarction and outpatient management.
Appendix: ACC National
Cardiovascular Data Registry—
Core Element List
Enrollment Core Data Elements (Required
With the First Cardiac Catheterization and
PTCA Hospitalization)
Total Core Elements: 6
Patient Demographics
CE1. Patient’s Last Name
CE2. Patient’s First Name
CE3. Patient’s Middle Initial
CE4. Patient’s Social Security Number (Social Insurance Number
if Canadian)
CE5. Patient’s Date of Birth (Date)
CE6. Patient’s Gender (Male, Female)
Admission Core Data Elements (Required With All
Cardiac Catheterization and PTCA Hospitalizations)
Total Core Elements: 24
Admission
CE7. Facility Number
CE8. Hospital
CE9. Date of Admission
Clinical Presentation
CE10. CHF Within Six Weeks (NYHA Class I, II, III, IV, Unkn)
CE11. Angina Type (No Angina, Atypical Chest Pain, Stable,
Unstable, Unkn)
CE12. Angina Class (0, I, II, III, IV, Unkn)
CE13. Acute or Recent Myocardial Infarction (No MI, Acute,
Recent, Unkn)
CE14. Thrombolysis (Yes/No/Unkn)
CE15. Objective Evidence of Ischemia (Yes/No/Unkn)
Previous Invasive Procedures
CE16. Previous Coronary Intervention (Yes/No/Unkn)
Previous Cardiovascular Surgery
CE17. Previous Coronary Artery Bypass Graft Surgery (CABG)
(Yes/No/Unkn)
CE18. Date Most Recent Previous CABG
CE19. Valvular Surgery (Yes/No/Unkn)
History/Risk Factors
CE20. Family History of CAD (Yes/No/Unkn)
CE21. History of Diabetes (Yes/No/Unkn)
CE22. Diabetic Therapy (None, Insulin, Oral, Diet, Any Combi-
nation of the Three, Unkn)
CE23. Renal Failure (Yes/No/Unkn)
CE24. Chronic Lung Disease (Yes/No/Unkn)
CE25. Cerebrovascular Disease (Yes/No/Unkn)
CE26. Peripheral Vascular Disease (Yes/No/Unkn)
CE27. Remote MI (Yes/No/Unkn)
CE28. Hypertension (Yes/No/Unkn)
CE29. Smoking History (Current, Former, Never, Unkn)
CE30. Hypercholesterolemia (Yes/No/Unkn)
Cardiac Catheterization Core Data Elements
Total Core Elements: 34
Procedure
CE31. Data of Cardiac Catheterization (Date)
CE32. Same Sitting as PTCA (Yes/No/Unkn)
Primary Operator
CE33. Catheterization Operator’s Name
CE34. Catheterization Operator’s Social Security Number
Indications
CD35. Congestive Heart Failure (Yes/No/Unkn)
CE36. Cardiogenic Shock (Yes/No/Unkn)
CE37. Valvular Heart Disease (Yes/No/Unkn)
CE38. Heart Disease of Other Etiology (Yes/No/Unkn)
CE39. Cardiac Arrest or Arrhythmia (Yes/No/Unkn)
CE40. Ischemic Heart Disease (Yes/No/Unkn)
CE41. Positive Functional Tests (Yes/No/Unkn)
Current Procedure
CE42. Urgency (Elective, Urgent, Emergent, Unkn)
CE43. IABP Sequence (Not Used, Before, During, Both, Unkn)
Cardiac Catheterization Procedure Laboratory Data
CE44. Left Ventriculogram (Yes/No/Unkn)
CE45. LV Status (Normal, Abnormal, Unkn)
CE46. Ejection Fraction Percent (%, Unkn)
CE47. Valve Disease (Yes/No/Unkn)
CE48. Pulmonary Hypertension (Yes/No/Unkn)
CE49. Severe Aortic Stenosis (Yes/No/Unkn)
Coronary Anatomy
CE50. Dominance (Left, Right, Mixed)
CE51. Stenosis Percent—LM (%)
CE52. Stenosis Percent—Proximal LAD (%)
CE53. Stenosis Percent—Other LAD (Distal/Diagonal) (%)
CE54. Stenosis Percent—RCA (%)
CE55. Stenosis Percent—CIRC (%)
In-Lab Complications
CE56. Any In-Lab Complications (Yes/No)
CE57. Q-Wave MI (Yes/No)
CE58. Cardiac Arrest (Yes/No)
CE59. CVA/Stroke (Yes/No)
CE60. Vascular Complications (Yes/No)
CE61. Tamponade (Yes/No)
Abbreviations and acronyms: CABG 5 coronary artery bypass graft surgery;
CAD 5 coronary artery disease; CHF 5 congestive heart failure; CIRC 5
circumflex coronary artery; CVA 5 cerebrovascular accident; DCA 5 direc-
tional coronary atherectomy; IABP 5 intraaortic balloon pump; IVUS 5
intravascular ultrasound; Lab 5 laboratory; LAD 5 left anterior descending
coronary artery; LM 5 left main coronary artery; LV 5 left ventricular; MI 5
myocardial infarction; NYHA 5 New York Heart Association; PC 5 personal
care; PTCA 5 percutaneous transluminal coronary angioplasty; RCA 5 right
coronary artery; TEC 5 transluminal extraction catheter; TIMI 5 Thrombolysis
in Myocardial Infarction; Unkn 5 unknown.
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CE62. Emergency CABG (Yes/No)
CE62. Emergency PTCA (Yes/No)
CE64. Death in Lab (Yes/No)
PTCA Core Data Elements
Total Core Elements: 59 (23 repeated for each lesion)
Procedure Date
CE65. Date of PTCA Procedure
Primary Operator
CE66. PTCA Operator’s Name
CE67. PTCA Operator’s Social Security Number
Indications
CE68. Coronary Lesion in a Major Coronary Artery (Yes/No/
Unkn)
CE69. Angina Pectoris (Yes/No/Unkn)
CE70. Significant Residual Lesion Present Following MI (Yes/
No/Unkn)
CE71. Significant, Residual or New Lesion Present Following
CABG (Yes/No/Unkn)
CE72. Restenosis Following an Interventional Procedure Present
(Yes/No/Unkn)
CE73. Acute MI Present (Yes/No/Unkn)
CE74. Positive Functional Tests (Yes/No/Unkn)
CE75. Cardiogenic Shock (Yes/No/Unkn)
Current Procedure
CE76. Urgency (Elective, Urgent, Emergent, Unkn)
CE77. Cardiopulmonary Support (Yes/No/Unkn)
CE78. IABP Sequence (Not Used, Before, During, Both, Unkn)
In-Lab Medications
CE79. In-Lab Thrombolytics (Yes/No/Unkn)
CE80. In-Lab GP 2B/3A Blockers (Yes/No/Unkn)
Coronary Anatomy
CE81. Preceded by Diagnostic Catheterization (Yes/No/
Unkn)
CE82. Ejection Fraction Percent (%, Unkn)
CE83. Dominance (Left, Right, Mixed)
CE84. Stenosis Percent—LM (%)
CE85. Stenosis Percent—Proximal LAD (%)
CE86. Stenosis Percent—Other LAD (%)
CE87. Stenosis Percent—RCA (%)
CE88. Stenosis Percent—CIRC (%)
CE89. Valve Disease (Yes/No/Unkn)
Procedure—Lesion Description (Complete for each lesion approached)
CE90. Lesion Identification Number
CE91. Segment Number
CE92. Pre-Stenosis Percent (%)
CE93. Pre-Stenosis Measurement Method (Visual Reading, Cal-
iper Reading Automated Edge Detection, Unkn)
CE94. Post-Stenosis Percent (%)
CE95. Post-Procedure TIMI Flow (0, 1, 2, 3)
CE96. Previously Dilated Lesion (Yes/No/Unkn)
CE97. In Graft to Cited Segment (Yes/No)
CE98. Location In Graft (Aortic, Body, Distal, Unkn)
CE99. Lesion Type (A, B1, B2, C)
PTCA Procedure Device (Complete for each lesion approached)
Choices: Balloon, DCA, Rotablator, TEC, Laser, IVUS, Stent, Other
CE100. First Pre-Treatment Device
CE101. Second Pre-Treatment Device
CE102. Primary Treatment Device
CE103. First Adjunct Treatment Device
CE104. Second Adjunct Treatment Device
CE105. Third Adjunct Treatment Device
CE106. First Bailout Device
CE107. Second Bailout Device
CE108. Third Bailout Device
Site Complications (Complete for each lesion approached)
CE109. Dissection (Yes/No)
CE110. Acute Closure (Yes/No)
CE111. Successful Reopening (Yes/No)
CE112. Perforation (Yes/No)
Procedure Complications
CE113. Any In-Lab Procedural Complications (Yes/No)
CE114. Q-Wave MI (Yes/No)
CE115. Cardiac Arrest (Yes/No)
CE116. CVA/Stroke (Yes/No)
CE117. Vascular Complications (Yes/No)
CE118. Tamponade (Yes/No)
CE119. Emergency CABG (Yes/No)
Ce120. Death In Lab (Yes/No)
Procedure Summary
CE121. Number of Lesions Attempted
CE122. Number of Lesions Successfully Dilated
CE123. Procedure Result (Successful, Incomplete, Unsuccessful)
Discharge Core Data Elements (Required for All
Admissions for PTCA, Even If In-Hospital Death,
Not Required if the Only Procedure Was an Out-
Patient Catheterization)
Total Core Elements: 18
Discharge Date
CE124. Date of Discharge
Post-Procedure Medications—In-Hospital
CE125. Post-Procedure Heparin (Hirudin, Hirulog) (Yes/No/Unkn)
CE126. Post-Procedure GP 2B/3A Blockers (Yes/No/Unkn)
Post-Procedure Data
CE127. Number of Procedures Performed
CE128. Multiple Procedures—Same Lesion (Yes/No/Unkn)
CE129. CABG During This Admission (Yes/No)
CE130. Date of CABG During This Admission (Date)
CE131. Urgency of CABG During This Admission (Elective,
Urgent, Emergent, Unkn)
CE132. Discharge Status (Home, Nursing/PC Home, Other Hos-
pital, Death, Unkn)
Out-of-Lab Complications
CE133. Any Out-of-Lab Complications (Yes/No)
CE134. Q-Wave MI (Yes/No)
CE135. Congestive Heart Failure (Yes/No)
CE136. Cardiac Arrest (Yes/No)
CE137. CVA/Stroke (Yes/No)
CE138. Renal Failure (Yes/No)
CE139. Vascular Complications (Yes/No)
CE140. Tamponade (Yes/No)
Mortality (in Hospital)
CE141. Death In Hospital (Yes/No)
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